Lupin Pharmaceuticals Inc. has recalled approximately 12,938 units of Kaitlib Fe (norethindrone and ethinyl estradiol) chewable birth control tablets. The recall was issued because the medication failed to meet purity and degradation standards during a long-term stability study. Using medication that has degraded or contains impurities may lead to reduced effectiveness or unexpected side effects. Consumers who have this prescription medication should consult their doctor or pharmacist immediately for guidance and a replacement.
The product exceeded specified limits for impurities or degradation products over time, which means the chemical composition of the tablets has changed. This can compromise the drug's intended potency and safety profile, potentially impacting the effectiveness of the birth control.
Contact healthcare provider and return product to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.